supplemented with 20% foetal calf serum (Flow Laboratories) , penicillin (lOOUml-1) and streptomycin (100 gml-1), and incubated in a humidified atmosphere of 95% air and 5% carbon dioxide at 37°C. Cells (2 x 105) were plated in 60mm plastic dishes (tissue culture Petri dish; Falcon). After 48 h incubation, the medium was replaced with fresh culture medium containing the desired concentrations of each drug, and the cell cultures were incubated for 1 h at 37°C. Duplicate cultures were set up at each of the concentrations, and assays were performed at least three times for each drug. After drug exposure the medium was removed, and the cells were rinsed twice with F-10 Our results demonstrate that 4-S-cysteinylcatechol, a sulphur homologue of L-dopa, is a remarkably potent agent in killing human melanoma cells as compared with L-dopa itself. The enhanced toxicity of 4-S-CC to melanoma cells may be related to the presence of a sulphur atom in the molecule, the only difference between 4-S-CC and L-dopa in chemical structure (Figure 1) . Ito et al. (1987) have indicated that 4-S-CC is a much better substrate for tyrosinase than Ldopa, suggesting that this may be due to the electron donating resonance effect of the sulphur atom. L-dopa and its analogues have been shown to be selectively cytotoxic to melanoma cells (Wick et al., 1977; Wick, 1978) , and its mechanism has been postulated to be tyrosinase-mediated oxidation of these compounds to o-quinone forms that inhibit the activity of DNA polymerase a (Graham et al., 1978; Wick, 1980) . Thus, .the enhanced toxicity of 4-S-CC may be ascribed to a significantly increased affinity for tyrosinase. In addition, the sulphur atom may also increase the incorporation of these compounds into cells by virtue of its lipophilicity (Ito et al., 1981) .
2-S-Cysteinylhydroquinone was next to 4-S-CC in killing melanoma cells. Hydroquinone itself has been shown to have melanocytolytic activity against melanocytes in vivo (Jimbow et al., 1974), and Chavin et al. (1980) showed that hydroquinone significantly prolongs the survival of melanoma-bearing mice. Recently, Penney et al. (1984) suggested that the cytotoxicity of hydroquinone to melanoma cells may be via its oxidation by tyrosinase. Thus, the potent killing activity of 2-S-CH may also be related to the tyrosinase-mediated oxidation of the hydroquinone moiety.
3-S-Cysteinyl-5-methylcatechol had an intermediate activity in killing melanoma cells among the drugs examined. Since Fujita et al. (1980) have demonstrated the 5-Scysteinyldopa, an intermediate in the pathway from L-dopa to pheomelanin, is much more cytotoxic to melanoma cells than L-dopa, the enhanced effect of 3-S-C-5-MC may be related to the fact that its chemical structure is closely analogous to that of 5-S-cysteinyldopa (Figure 1) .
Our results indicate that 4-S-CC and its analogues possess remarkably potent killing activities to human melanoma cells, and that these effects are closely related to their chemical structure. L-dopa was found to have only a weak killing effect, though it has been reported that L-dopa inhibits selectively the growth of melanoma cells (Wick et al., 1977) . Thus, 4-S-CC and analogues may make a new, effective cytotoxic agent for the rational chemotherapy that can ameliorate malignant melanoma.
